This Monday morning session was arranged by Michael E. Swartz, of Synomics Pharmaceutical Services (Wareham, Massachusetts). Unfortunately, Swartz was unable to preside over the session or deliver a presentation as planned due to a cancelled flight to Chicago. Ken Fountain of Waters Corporation (Milford, Massachusetts) filled in ably for Swartz in presiding over the session.
This Monday morning session was arranged by Michael E. Swartz, of Synomics Pharmaceutical Services (Wareham, Massachusetts). Unfortunately, Swartz was unable to preside over the session or deliver a presentation as planned due to a cancelled flight to Chicago. Ken Fountain of Waters Corporation (Milford, Massachusetts) filled in ably for Swartz in presiding over the session.
Chromatography with sub-2-µm particles currently is a hot topic in separation science because of its potential for high resolution separations and reduced solvent consumption. Many instrument manufacturers have focused their efforts on this area.
The session began with a presentation by Ken Fountain titled “Achieving Maximum Performance with Sub-2-µm Particles.” The presentation focused on the effects of system volume, operating pressure, and separation temperature on separations using sub-2-µm particle columns.
Richard Verseput of S-Matrix (Eureka, California) presented a talk titled “A Quality-by-Design Methodology for Rapid LC Method Development.” Verseput’s presentation described an approach for the development of robust LC methods. The goal of the approach is to accelerate the column screening process and identify optimum LC instrument settings.
A presentation given by Rachel A. Lieberman of the University of North Carolina at Chapel Hill was titled “Investigations of Column Packing Technology Using 1.0-µm Bridged Ethyl Hybrid Particles in Ultrahigh-Pressure Liquid Chromatography.” The bridged ethyl hybrid particles were suspended in acetone, tetrahydrofuran, and methyl ethyl ketone, and the effects of the various solvents on column packing and performance were investigated.
After a brief recess, Michael W. Dong of Genentech (South San Francisco, California) presented a talk titled “Potential Issues of Ultrahigh-Pressure LC Using Sub-2-µm Columns in Regulated Analysis.” His talk focused on various areas of concern in using sub-2-µm columns, including safety issues, compatibility with conventional columns and methods, injection precision and carryover, detector sensitivity, and system reliability and ease of use.
Mark Jacyno of Grace Davison Discovery Sciences (Deerfield, Illinois) then presented “Ultrahigh-Pressure LC Selectivity Options for High-Speed Separations.” Jacyno’s talk described and discussed the use of various sub-2-µm phases with complementary selectivities for pharmaceutical, environmental, and biotech applications.
The penultimate presentation in the session was titled “Using Fused-Core Particle Technology to Achieve Near Sub-2-µm Performance Using Conventional HPLC Equipment” and was presented by Thomas Waeghe of MAC-MOD Analytical (Chadds Ford, Pennsylvania). The presentation discussed research conducted using the company’s Fused-Core particles and HALO columns.
The session’s final presentation was given by Frank Dorman of Restek Corporation (Bellefonte, Pennsylvania) and was titled “The Role and Importance of Particle Dimensions and Stationary Phase Chemistry for Silica-Based UHPLC Columns.” In his presentation, Dorman discussed the effects of particle size, particle size distribution, and stationary phase selectivity on performance and column selection.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.